Mitral Valve Screening Survey
ConditionMitral Valve Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedstar Health Research Institute
About this trial
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject failed screening for TMVI
Disqualifiers
Under 18 years of age
Subject unable or unwilling to give informed consent
Subject proceeded with TMVI.
Trial population
This multicenter prospective study will enroll consecutive subjects, who after referral for TMVI, are deemed not to be candidates for TMVI.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: Subjects fail screening for TMVI
Trial outcomes
Primary outcomes
1
All-cause mortality
Time frame
1 yearSecondary outcomes
1
Reason for screen failure
Time frame
Baseline2
All-cause mortality
Time frame
30 days, 1 year, and annually up to 5 years3
Hospitalizations
Time frame
30 days, 1 year, and annually up to 5 years4
Mitral intervention
Time frame
30 days, 1 year, and annually up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov